Approval · Notice of Compliance 37020 · 2026
COMPUDOSE: Notice of Compliance 37020
Issued March 4, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37020
- Date
- March 4, 2026
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPUDOSE | 00590932 | Marketed |
Medicinal ingredients
- ESTRADIOL 25.7 MG per IMP